Multiple signaling pathways in the frontiers of lung cancer progression

Lung cancer is a prevalent malignant tumor and the leading cause of cancer-related mortality worldwide. LC is a complex respiratory condition that poses significant challenges for both clinicians and researchers. Crucially, dysregulation of molecular signaling pathways is a key message point in LC....

Full description

Saved in:
Bibliographic Details
Main Authors: Hao Liu, Dujuan Zhou, Yangjing Ou, Shuanghua Chen, Yunzhu Long, Ting Yuan, Yukun Li, Yingzheng Tan
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1593793/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850214248510128128
author Hao Liu
Dujuan Zhou
Yangjing Ou
Shuanghua Chen
Yunzhu Long
Ting Yuan
Yukun Li
Yingzheng Tan
Yingzheng Tan
author_facet Hao Liu
Dujuan Zhou
Yangjing Ou
Shuanghua Chen
Yunzhu Long
Ting Yuan
Yukun Li
Yingzheng Tan
Yingzheng Tan
author_sort Hao Liu
collection DOAJ
description Lung cancer is a prevalent malignant tumor and the leading cause of cancer-related mortality worldwide. LC is a complex respiratory condition that poses significant challenges for both clinicians and researchers. Crucially, dysregulation of molecular signaling pathways is a key message point in LC. Numerous reviews have highlighted effective treatments for LC by targeting disrupted signaling pathways. Understanding the roles and interconnections of various signaling pathways in LC is crucial. Therefore, this paper reviews the pathogenesis, biological functions and their important interactions in lung cancer. Frist, we reviewed relevant signaling pathways involved in LC, including Wnt, PI3K/Akt, Notch, PD-1/PD-L1, NF-κB, Hippo, MAPK, Hedgehog, AMPK. Immediately thereafter, we further explored the biological functions of LC in this area of pathophysiology, such as apoptosis, metastasis and proliferation. In conclusion, after our deeper understanding of the interactions of these signaling pathways in LC. And we must recognize that the interactions between the above signaling pathways can lead to comprehensive as well as novel therapeutic approaches for LC.
format Article
id doaj-art-04291e792cf8472cb9abca5165b0aa45
institution OA Journals
issn 1664-3224
language English
publishDate 2025-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-04291e792cf8472cb9abca5165b0aa452025-08-20T02:08:57ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-06-011610.3389/fimmu.2025.15937931593793Multiple signaling pathways in the frontiers of lung cancer progressionHao Liu0Dujuan Zhou1Yangjing Ou2Shuanghua Chen3Yunzhu Long4Ting Yuan5Yukun Li6Yingzheng Tan7Yingzheng Tan8Zhuzhou Clinical College, Jishou University, Zhuzhou, Hunan, ChinaDepartment of Infectious Disease, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, Hunan, ChinaDepartment of Infectious Disease, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, Hunan, ChinaHunan Traditional Chinese Medicine College, Zhuzhou, Hunan, ChinaDepartment of Infectious Disease, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, Hunan, ChinaDepartment of Infectious Disease, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, Hunan, ChinaDepartment of Assisted Reproductive Centre, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, Hunan, ChinaZhuzhou Clinical College, Jishou University, Zhuzhou, Hunan, ChinaDepartment of Infectious Disease, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, Hunan, ChinaLung cancer is a prevalent malignant tumor and the leading cause of cancer-related mortality worldwide. LC is a complex respiratory condition that poses significant challenges for both clinicians and researchers. Crucially, dysregulation of molecular signaling pathways is a key message point in LC. Numerous reviews have highlighted effective treatments for LC by targeting disrupted signaling pathways. Understanding the roles and interconnections of various signaling pathways in LC is crucial. Therefore, this paper reviews the pathogenesis, biological functions and their important interactions in lung cancer. Frist, we reviewed relevant signaling pathways involved in LC, including Wnt, PI3K/Akt, Notch, PD-1/PD-L1, NF-κB, Hippo, MAPK, Hedgehog, AMPK. Immediately thereafter, we further explored the biological functions of LC in this area of pathophysiology, such as apoptosis, metastasis and proliferation. In conclusion, after our deeper understanding of the interactions of these signaling pathways in LC. And we must recognize that the interactions between the above signaling pathways can lead to comprehensive as well as novel therapeutic approaches for LC.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1593793/fullsignal transductionlung cancertherapeutic targetsoncogenemetastasis
spellingShingle Hao Liu
Dujuan Zhou
Yangjing Ou
Shuanghua Chen
Yunzhu Long
Ting Yuan
Yukun Li
Yingzheng Tan
Yingzheng Tan
Multiple signaling pathways in the frontiers of lung cancer progression
Frontiers in Immunology
signal transduction
lung cancer
therapeutic targets
oncogene
metastasis
title Multiple signaling pathways in the frontiers of lung cancer progression
title_full Multiple signaling pathways in the frontiers of lung cancer progression
title_fullStr Multiple signaling pathways in the frontiers of lung cancer progression
title_full_unstemmed Multiple signaling pathways in the frontiers of lung cancer progression
title_short Multiple signaling pathways in the frontiers of lung cancer progression
title_sort multiple signaling pathways in the frontiers of lung cancer progression
topic signal transduction
lung cancer
therapeutic targets
oncogene
metastasis
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1593793/full
work_keys_str_mv AT haoliu multiplesignalingpathwaysinthefrontiersoflungcancerprogression
AT dujuanzhou multiplesignalingpathwaysinthefrontiersoflungcancerprogression
AT yangjingou multiplesignalingpathwaysinthefrontiersoflungcancerprogression
AT shuanghuachen multiplesignalingpathwaysinthefrontiersoflungcancerprogression
AT yunzhulong multiplesignalingpathwaysinthefrontiersoflungcancerprogression
AT tingyuan multiplesignalingpathwaysinthefrontiersoflungcancerprogression
AT yukunli multiplesignalingpathwaysinthefrontiersoflungcancerprogression
AT yingzhengtan multiplesignalingpathwaysinthefrontiersoflungcancerprogression
AT yingzhengtan multiplesignalingpathwaysinthefrontiersoflungcancerprogression